Scientific paper - Case study
Miller Fisher syndrome following Pfizer COVID-19 vaccine
Neurological Sciences, 43 (2022), 3; 1495-1497. https://doi.org/10.1007/s10072-021-05776-0

Abičić, Ana; Adamec, Ivan; Habek, Mario

Linked objects
COVID-19 | Virtual collection
Cite this document

Abičić, A., Adamec, I. & Habek, M. (2022). Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurological Sciences, 43. (3), 1495-1497. doi: 10.1007/s10072-021-05776-0

Abičić, Ana, et al. "Miller Fisher syndrome following Pfizer COVID-19 vaccine." Neurological Sciences, vol. 43, no. 3, 2022, pp. 1495-1497. https://doi.org/10.1007/s10072-021-05776-0

Abičić, Ana, Ivan Adamec and Mario Habek. "Miller Fisher syndrome following Pfizer COVID-19 vaccine." Neurological Sciences 43, no. 3 (2022): 1495-1497. https://doi.org/10.1007/s10072-021-05776-0

Abičić, A., Adamec, I. and Habek, M. (2022) 'Miller Fisher syndrome following Pfizer COVID-19 vaccine', Neurological Sciences, 43(3), pp. 1495-1497. doi: 10.1007/s10072-021-05776-0

Abičić A, Adamec I, Habek M. Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurological Sciences [Internet]. 2022 March [cited 2024 July 25];43(3):1495-1497. doi: 10.1007/s10072-021-05776-0

A. Abičić, I. Adamec and M. Habek, "Miller Fisher syndrome following Pfizer COVID-19 vaccine", Neurological Sciences, vol. 43, no. 3, pp. 1495-1497, March 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:851869. [Accessed: 25 July 2024]

Please login to the repository to save this object to your list.